Literature DB >> 8824029

The anticoagulant, antithrombotic and haemorrhagic effect of long-term warfarin on experimental venous and arterial thrombosis in the rat.

M MacIomhair1, S M Lavelle.   

Abstract

The amount of thrombus formed in one hour, on standard platinum wire in aorta and vena cava of 48 control and 96 warfarin treated rats of both sexes, was measured. Warfarin was given in varying doses (0.1-0.18 mg/kg) for ten consecutive days before operation to enable the coagulation factors to stabilize. Factors II, VII and X levels as well as prothrombin time (PT) values were obtained for each animal. Factor levels and PT ratio were related to reduction in arterial and venous thrombus weight. The relation between reduction in thrombus weight and depletion in coagulation factor levels was best for factor II and fairly good for factor X at all levels of anticoagulation. All animals which were haemorrhagic had factor II levels of below 15%, with a mean of 8%. At low warfarin dosage a significant reduction of thrombus (> 30%) went undetected by any test, but was least frequently undetected by factor II and most frequently undetected by PT. All rats with diminished thrombus had at least one factor depleted. Haemorrhagic animals were found with any PT ratio in excess of unity. Factor II reflected antithrombotic and haemorrhagic effects of warfarin much better than factors X, VII, or PT.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824029     DOI: 10.1007/bf02940253

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  38 in total

Review 1.  Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.

Authors:  J Hirsh; J E Dalen; D Deykin; L Poller
Journal:  Chest       Date:  1992-10       Impact factor: 9.410

2.  Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the rat.

Authors:  G F Smith; B L Neubauer; J L Sundboom; K L Best; R L Goode; L R Tanzer; R L Merriman; J D Frank; R G Herrmann
Journal:  Thromb Res       Date:  1988-04-01       Impact factor: 3.944

3.  Effects of antithrombotic agents evaluated in a nonhuman primate vascular shunt model.

Authors:  R G Mason; R H Wolf; W H Zucker; B A Shinoda; S F Mohammad
Journal:  Am J Pathol       Date:  1976-06       Impact factor: 4.307

4.  Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions.

Authors:  C S Landefeld; M W Rosenblatt; L Goldman
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

5.  Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.

Authors:  A Zivelin; L V Rao; S I Rapaport
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

6.  Protective effect of warfarin in arterial thrombosis: evidence from a vascular prosthesis model in rats.

Authors:  I Reyers; G de Gaetano; M B Donati
Journal:  Thromb Haemost       Date:  1983-12-30       Impact factor: 5.249

7.  A modified stasis thrombosis model to study the antithrombotic actions of heparin and its fractions.

Authors:  J Fareed; J M Walenga; A Kumar; A Rock
Journal:  Semin Thromb Hemost       Date:  1985-04       Impact factor: 4.180

8.  Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin.

Authors:  D B Petitti; B L Strom; K L Melmon
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

9.  A new primate model for the study of intravenous thrombotic potential and its modification.

Authors:  N A Shoenfeld; A Yeager; R Connolly; K Ramberg; L Forgione; A Giorgio; C R Valeri; A D Callow
Journal:  J Vasc Surg       Date:  1988-07       Impact factor: 4.268

10.  Thrombus weight as a measure of hypercoagulability induced by drugs.

Authors:  M MacIomhair; S M Lavelle
Journal:  Thromb Haemost       Date:  1979-10-31       Impact factor: 5.249

View more
  1 in total

1.  Bleeding times and the antithrombotic effects of high-dose aspirin, hirudin and heparins in the rat.

Authors:  S M Lavelle; M MacIomhair
Journal:  Ir J Med Sci       Date:  1998 Oct-Dec       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.